Trial NCT04625114
Publication Tobback E, Int J Infect Dis (2022) (published paper)
Dates: 2020-11-04 to 2021-06-30
Funding: Mixed (Ono Pharmaceuticals Co. Ltd. (Osaka, Japan) provided the study drug, camostat mesylate. Byteflies (Antwerp, Belgium) provided telemonitoring devices and technological support. No further funding was received.)
Conflict of interest: No